Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Surface-Templated Nanobubbles Protect Proteins from Surface-Mediated Denaturation.

Bull DS, Kienle DF, Chaparro Sosa AF, Nelson N, Roy S, Cha JN, Schwartz DK, Kaar JL, Goodwin AP.

J Phys Chem Lett. 2019 Jun 6;10(11):2641-2647. doi: 10.1021/acs.jpclett.9b00806. Epub 2019 May 8.

PMID:
31067058
2.

Emerging Attractor in Wavy Poiseuille Flows Triggers Sorting of Biological Cells.

Laumann M, Schmidt W, Farutin A, Kienle D, Förster S, Misbah C, Zimmermann W.

Phys Rev Lett. 2019 Mar 29;122(12):128002. doi: 10.1103/PhysRevLett.122.128002.

PMID:
30978078
3.

Standalone interferometry-based calibration of convex lens-induced confinement microscopy with nanoscale accuracy.

Morrin GT, Kienle DF, Schwartz DK.

Analyst. 2019 Apr 8;144(8):2628-2634. doi: 10.1039/c8an02300j.

PMID:
30839956
4.

Complex Salt Dependence of Polymer Diffusion in Polyelectrolyte Multilayers.

Kienle DF, Schwartz DK.

J Phys Chem Lett. 2019 Mar 7;10(5):987-992. doi: 10.1021/acs.jpclett.9b00004. Epub 2019 Feb 19.

PMID:
30768907
5.

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10.

Kienle DL, Dietrich D, Ribi K, Wicki A, Quagliata L, Winterhalder RC, Koeberle D, Horber D, Bastian S, Kueng M, Saletti P, Helbling D, Baertschi D, Lugli A, Bernhard J, Andrieu C, von Moos R.

J Geriatr Oncol. 2019 Mar;10(2):304-310. doi: 10.1016/j.jgo.2018.11.011. Epub 2018 Dec 14.

PMID:
30559073
6.

Correlating Structural and Functional Heterogeneity of Immobilized Enzymes.

Kienle DF, Falatach RM, Kaar JL, Schwartz DK.

ACS Nano. 2018 Aug 28;12(8):8091-8103. doi: 10.1021/acsnano.8b02956. Epub 2018 Aug 6.

PMID:
30067333
7.

Stabilization of Immobilized Enzymes via the Chaperone-Like Activity of Mixed Lipid Bilayers.

Chaparro Sosa AF, Kienle DF, Falatach RM, Flanagan J, Kaar JL, Schwartz DK.

ACS Appl Mater Interfaces. 2018 Jun 13;10(23):19504-19513. doi: 10.1021/acsami.8b05523. Epub 2018 May 29.

PMID:
29767959
8.

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.

Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, Ntoufa S, Tausch E, Yan XJ, Shanafelt T, Plevova K, Boudjogra M, Rossi D, Davis Z, Navarro A, Sandberg Y, Vojdeman FJ, Scarfo L, Stavroyianni N, Sudarikov A, Veronese S, Tzenou T, Karan-Djurasevic T, Catherwood M, Kienle D, Chatzouli M, Facco M, Bahlo J, Pott C, Pedersen LB, Mansouri L, Smedby KE, Chu CC, Giudicelli V, Lefranc MP, Panagiotidis P, Juliusson G, Anagnostopoulos A, Vlahavas I, Antic D, Trentin L, Montillo M, Niemann C, Döhner H, Langerak AW, Pospisilova S, Hallek M, Campo E, Chiorazzi N, Maglaveras N, Oscier D, Gaidano G, Jelinek DF, Stilgenbauer S, Chouvarda I, Darzentas N, Belessi C, Davi F, Hadzidimitriou A, Rosenquist R, Ghia P, Stamatopoulos K.

Clin Cancer Res. 2017 Sep 1;23(17):5292-5301. doi: 10.1158/1078-0432.CCR-16-3100. Epub 2017 May 23.

9.

Analyzing refractive index profiles of confined fluids by interferometry part II: Multilayer and asymmetric systems.

Kienle DF, Kuhl TL.

Anal Chim Acta. 2016 Sep 14;936:236-44. doi: 10.1016/j.aca.2016.07.009. Epub 2016 Jul 16.

PMID:
27566361
10.

Density and Phase State of a Confined Nonpolar Fluid.

Kienle DF, Kuhl TL.

Phys Rev Lett. 2016 Jul 15;117(3):036101. doi: 10.1103/PhysRevLett.117.036101. Epub 2016 Jul 14.

11.

Analyzing refractive index profiles of confined fluids by interferometry.

Kienle DF, Kuhl TL.

Anal Chem. 2014 Dec 2;86(23):11860-7. doi: 10.1021/ac503469x. Epub 2014 Nov 18.

PMID:
25365770
12.

Thickness and refractive index of DPPC and DPPE monolayers by multiple-beam interferometry.

Kienle DF, de Souza JV, Watkins EB, Kuhl TL.

Anal Bioanal Chem. 2014 Jul;406(19):4725-33. doi: 10.1007/s00216-014-7866-9. Epub 2014 May 21.

PMID:
24842403
13.

Strain-induced optical changes in demineralized bone.

Hardisty MR, Kienle DF, Kuhl TL, Stover SM, Fyhrie DP.

J Biomed Opt. 2014 Mar;19(3):35001. doi: 10.1117/1.JBO.19.3.035001.

14.

[The spleen in hematologic malignancies].

Kienle DL.

Ther Umsch. 2013 Mar;70(3):163-9. doi: 10.1024/0040-5930/a000385. Review. German.

PMID:
23454563
15.

Telomere length in mantle cell lymphoma.

Jebaraj BM, Kienle D, Lechel A, Mertens D, Heuberger M, Ott G, Rosenwald A, Barth TF, Möller P, Zenz T, Döhner H, Stilgenbauer S.

Blood. 2013 Feb 14;121(7):1184-7. doi: 10.1182/blood-2012-08-452649. Epub 2012 Dec 14.

16.

BRAF mutations in chronic lymphocytic leukemia.

Jebaraj BM, Kienle D, Bühler A, Winkler D, Döhner H, Stilgenbauer S, Zenz T.

Leuk Lymphoma. 2013 Jun;54(6):1177-82. doi: 10.3109/10428194.2012.742525. Epub 2012 Nov 20.

PMID:
23088640
17.

Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung.

Lammel V, Stoeckle C, Padberg B, Zweifel R, Kienle DL, Reinhart WH, Simon HU.

Lung Cancer. 2012 Jun;76(3):493-5. doi: 10.1016/j.lungcan.2012.02.014. Epub 2012 Mar 13.

PMID:
22420949
18.

Shear-flow-enhanced barrier crossing.

Kienle D, Bammert J, Zimmermann W.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Oct;84(4 Pt 1):042102. Epub 2011 Oct 18.

PMID:
22181206
19.

Identifying hydrodynamic interaction effects in tethered polymers in uniform flow.

Kienle D, Rzehak R, Zimmermann W.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jun;83(6 Pt 1):062802. Epub 2011 Jun 29.

PMID:
21797426
20.

Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia.

Kienle D, Benner A, Läufle C, Winkler D, Schneider C, Bühler A, Zenz T, Habermann A, Jäger U, Lichter P, Dalla-Favera R, Döhner H, Stilgenbauer S.

Haematologica. 2010 Jan;95(1):102-9. doi: 10.3324/haematol.2009.010298. Epub 2009 Nov 30.

21.

Terahertz response of carbon nanotube transistors.

Kienle D, Léonard F.

Phys Rev Lett. 2009 Jul 10;103(2):026601. Epub 2009 Jul 6.

PMID:
19659227
22.

miR-34a as part of the resistance network in chronic lymphocytic leukemia.

Zenz T, Mohr J, Eldering E, Kater AP, Bühler A, Kienle D, Winkler D, Dürig J, van Oers MH, Mertens D, Döhner H, Stilgenbauer S.

Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21.

23.

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.

Katzenberger T, Kienle D, Stilgenbauer S, Höller S, Schilling C, Mäder U, Puppe B, Petzoldt C, Sander S, Bullinger L, Stöcklein H, Kalla J, Hartmann E, Adam P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G.

Br J Haematol. 2008 Aug;142(4):538-50. doi: 10.1111/j.1365-2141.2008.07199.x. Epub 2008 Jun 28.

PMID:
18564361
24.

The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.

Zenz T, Häbe S, Benner A, Kienle D, Döhner H, Stilgenbauer S.

Haematologica. 2008 Jul;93(7):1111-3. doi: 10.3324/haematol.12738. Epub 2008 May 27. No abstract available.

25.

Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.

Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T, Kalla J, Ott G, Müller-Hermelink HK, Barth TF, Möller P, Lichter P, Döhner H, Stilgenbauer S.

Haematologica. 2008 May;93(5):680-7. doi: 10.3324/haematol.12330. Epub 2008 Mar 26.

26.

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.

Roos G, Kröber A, Grabowski P, Kienle D, Bühler A, Döhner H, Rosenquist R, Stilgenbauer S.

Blood. 2008 Feb 15;111(4):2246-52. Epub 2007 Nov 28.

27.

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.

Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, Winkler D, Kröber A, Kienle D, Lichter P, Döhner H.

Haematologica. 2007 Sep;92(9):1242-5. Epub 2007 Aug 1.

28.

Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.

Kainz B, Shehata M, Bilban M, Kienle D, Heintel D, Krömer-Holzinger E, Le T, Kröber A, Heller G, Schwarzinger I, Demirtas D, Chott A, Döhner H, Zöchbauer-Müller S, Fonatsch C, Zielinski C, Stilgenbauer S, Gaiger A, Wagner O, Jäger U.

Int J Cancer. 2007 Nov 1;121(9):1984-93.

29.

Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.

Kienle D, Katzenberger T, Ott G, Saupe D, Benner A, Kohlhammer H, Barth TF, Höller S, Kalla J, Rosenwald A, Müller-Hermelink HK, Möller P, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2007 Jul 1;25(19):2770-7. Epub 2007 Jun 11.

PMID:
17563396
30.

Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.

Mertens D, Wolf S, Tschuch C, Mund C, Kienle D, Ohl S, Schroeter P, Lyko F, Döhner H, Stilgenbauer S, Lichter P.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7741-6. Epub 2006 May 9.

31.

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.

Kröber A, Bloehdorn J, Hafner S, Bühler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2006 Feb 20;24(6):969-75. Epub 2006 Jan 17.

PMID:
16418492
32.

Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.

Kienle D, Benner A, Kröber A, Winkler D, Mertens D, Bühler A, Seiler T, Jäger U, Lichter P, Döhner H, Stilgenbauer S.

Blood. 2006 Mar 1;107(5):2090-3. Epub 2005 Dec 1.

33.

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.

Thorsélius M, Kröber A, Murray F, Thunberg U, Tobin G, Bühler A, Kienle D, Albesiano E, Maffei R, Dao-Ung LP, Wiley J, Vilpo J, Laurell A, Merup M, Roos G, Karlsson K, Chiorazzi N, Marasca R, Döhner H, Stilgenbauer S, Rosenquist R.

Blood. 2006 Apr 1;107(7):2889-94. Epub 2005 Nov 29.

34.

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.

Skogsberg S, Tobin G, Kröber A, Kienle D, Thunberg U, Aleskog A, Karlsson K, Laurell A, Merup M, Vilpo J, Sundström C, Roos G, Jernberg-Wiklund H, Döhner H, Nilsson K, Stilgenbauer S, Rosenquist R.

Leukemia. 2006 Jan;20(1):77-81.

PMID:
16307023
35.

Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.

Kienle DL, Korz C, Hosch B, Benner A, Mertens D, Habermann A, Kröber A, Jäger U, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2005 Jun 1;23(16):3780-92. Epub 2005 May 2.

PMID:
15867199
36.

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.

Heintel D, Kienle D, Shehata M, Kröber A, Kroemer E, Schwarzinger I, Mitteregger D, Le T, Gleiss A, Mannhalter C, Chott A, Schwarzmeier J, Fonatsch C, Gaiger A, Döhner H, Stilgenbauer S, Jäger U; CLL Study Group.

Leukemia. 2005 Jul;19(7):1216-23.

PMID:
15858619
37.

Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.

Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TF, Möller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Döhner H, Lichter P, Bentz M.

Blood. 2004 Aug 1;104(3):795-801. Epub 2004 Apr 13.

38.

High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.

Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J, Marculescu R, Le T, Mannhalter C, Gaiger A, Stilgenbauer S, Döhner H, Fonatsch C, Jäger U; German CLL Study Group.

Leukemia. 2004 Apr;18(4):756-62.

PMID:
14961036
39.

VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.

Kienle D, Kröber A, Katzenberger T, Ott G, Leupolt E, Barth TF, Möller P, Benner A, Habermann A, Müller-Hermelink HK, Bentz M, Lichter P, Dōhner H, Stilgenbauer S.

Blood. 2003 Oct 15;102(8):3003-9. Epub 2003 Jul 3.

40.

Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.

Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF, Nessling M, Möller P, Döhner H, Lichter P, Bentz M.

Oncogene. 2003 Mar 6;22(9):1425-9.

PMID:
12618769
41.

Topology of double minutes (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines.

Solovei I, Kienle D, Little G, Eils R, Savelyeva L, Schwab M, Jäger W, Cremer C, Cremer T.

Genes Chromosomes Cancer. 2000 Dec;29(4):297-308.

PMID:
11066073
42.

Separate and variably shaped chromosome arm domains are disclosed by chromosome arm painting in human cell nuclei.

Dietzel S, Jauch A, Kienle D, Qu G, Holtgreve-Grez H, Eils R, Münkel C, Bittner M, Meltzer PS, Trent JM, Cremer T.

Chromosome Res. 1998 Jan;6(1):25-33.

PMID:
9510507
43.

Surface boundary conditions for the Ginzburg-Landau theory of d-wave superconductors.

Alber M, Bäuml B, Ernst R, Kienle D, Kopf A, Rouchal M.

Phys Rev B Condens Matter. 1996 Mar 1;53(9):5863-5871. No abstract available.

PMID:
9984195
44.

[Performance, pulse and metabolism of health resort patients during walking and during ergometry training].

Hille H, Kienle D, Kienle H.

Med Welt. 1981 Jul 10;32(28):1119-22. German. No abstract available.

PMID:
7266342

Supplemental Content

Loading ...
Support Center